Email not displaying correctly?  View it in your browser.
Volume 9, Issue 1, March 2020

Director's message: The best is yet to come
Dr. Diasio reflects on the strengths of Mayo Clinic as he prepares for the next phase in his journey.
Mayo Clinic plans first carbon ion therapy facility in North America
The innovative technology provides new treatment options for challenging and resistant cancers.
Early sign of CV disease might serve as cancer risk marker
Patients with microvascular endothelial dysfunction were more likely to develop a solid tumor cancer.
Native Americans have significant cancer treatment concerns
A Mayo Clinic oncologist is calling for culturally specific education and treatment strategies.
Researchers discover new vulnerable target in cancer cells
An antibody developed at Mayo Clinic can make tumors more sensitive to radiotherapy and chemotherapy.
Anti-inflammatories may offer help against breast cancer risk
Women who used ibuprofen or naproxen after a benign breast biopsy reduced their cancer risk, research shows.
New inhibitor may work against pancreatic adenocarcinoma
Mayo Clinic researchers have found a way that could sensitize tumor cell lines to gemcitabine.
Meet the Investigator: Michael B. Wallace, M.D.
In this Cancer Center video, Dr. Wallace discusses research on early detection of pancreatic cancer.
Mayo Clinic Cancer Center
13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First Street SW
Rochester, MN 55905